A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 6, 2016

Primary Completion Date

January 28, 2018

Study Completion Date

December 31, 2018

Conditions
Ankylosing Spondylitis
Interventions
BIOLOGICAL

ENIA11

BIOLOGICAL

Placebo

Trial Locations (6)

333

Chang Gung Memorial Hospital, Taoyuan District

Unknown

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Chung Shan Medical University Hospital, Taichung

Far Eastern Memorial Hospital, Taipei

Taipei City Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

TSH Biopharm Corporation Limited

INDUSTRY

lead

Mycenax Biotech Inc.

INDUSTRY